Skip to main content

Table 2 Pathogenicity evaluation of two variants based on in-depth ACMG guideline application

From: The TECTA mutation R1890C is identified as one of the causes of genetic hearing loss: a case report

Gene

Variant

Literature reported the variant

In-depth ACMG guideline interpretation

Literature 1

Literature 2

Original ACMG guideline application

Hearing loss-specified ACMG guideline applicationa

  

PMID (year)

Evidential level

PMID (year)

Evidential level

Pathogenic components

Benign components

Final Result

Pathogenic components

Benign components

Final Result

TECTA

R1890C

16718611 (2006)

Clinical report of 1 family with segregation

28946916 (2017)

Clinical report of 3 families with segregation

PS2, PM2, PP3, PP5

no component

Likely pathogenic

PS2_Moderate, PS4_Supporting, PM2, PP1_Strong, PP3

no component

Pathogenic

H1400Y

22718023 (2012)

Clinical report of 1 family with segregation

23967202 (2013)

Simple clinical report without segregation

PP3, PP5

BS2

Variant of uncertain significance

PP3

BS1, BS2

Benign

  1. aSpecified ACMG hearing loss rules suggested by the ClinGen Hearing Loss Clinical Domain Working Group were applied [15]
  2. Abbreviations: ACMG American College of Medical Genetics and Genomics, PMID pubmed ID, PS pathogenic strong, PM pathogenic moderate, PP pathogenic support
  3. PS2, 1 proven de novo occurrence; PM2, absent in population databases; PP3, multiple computational evidence; PP5, recent reputable source without functional evidence; BS2, observation on in controls inconsistent with disease penetrance; PS2_Moderate, 1 proven de novo occurrence (phenotype consistent but not specific to gene); PS4_Supporting, Autosomal dominant: ≥2 probands with variant, and variant meets; PM2, Absent/rare in population databases; PP1_Strong, Segregation in one affected relative for recessive and two affected relatives for dominant; BS1, MAF of ≥0.003 (0.3%) for autosomal recessive; MAF of ≥0.0002 (0.02%) for autosomal dominant. Likely benign, provided there is no conflicting evidence